Senior Software Engineer, Freenome
$161.9-247k
+ Pre-IPO equity + Cash bonuses
Biological analysis platform for cancer
Be an early applicant
Biological analysis platform for cancer
501-1000 employees
Be an early applicant
$161.9-247k
+ Pre-IPO equity + Cash bonuses
501-1000 employees
Company mission
To reinvent disease management through early detection and precision intervention.
Role
Who you are
- The ideal candidate is an experienced backend engineer with a strong background in developing scalable and reliable software solutions
- This position requires a collaborative mindset, as you will work closely with an interdisciplinary team of engineers, scientists, and product managers to deliver high-quality software solutions
- You are passionate about software development best practices and will have a significant impact on the continued growth of an organization dedicated to changing the entire landscape of cancer
- Bachelor of Science in Computer Science, Engineering, or related field or equivalent training, fellowship, and/or work experience
- At least 8 years of experience as part of a software development team successfully shipping software products, including leading projects from end-to-end and mentoring others
- Proficiency in Python and experience with backend development in a team production environment
- Strong experience with containerization and orchestration technologies such as Docker and Kubernetes
- Familiarity with cloud platforms like AWS, Azure, or Google Cloud Platform
- Proven experience in designing and implementing scalable backend systems, with a focus on reliability and performance
- Excellent written and verbal communication skills, with a mindful and transparent approach to collaboration
Desirable
- Understanding of statistical and machine learning methods, with practical experience in applying them to real-world problems
- Expertise in developing ETL or data pipelines that run at scale, utilizing common workflow management systems like Flyte, Airflow, or similar
- Domain-specific experience in computational biology, genomics, or a related field
- Experience working in an FDA regulated environment, with a strong understanding of compliance requirements and best practices
What the job involves
- At Freenome, we are seeking a Senior Software Engineer II to join our innovative Engineering team
- You will play a crucial role in designing, building, and maintaining backend services that support our mission to detect cancer early
- The role reports to our engineering management team
- Design, develop, and deploy reliable, maintainable, scalable, and fault-tolerant backend services that power both our internal and external systems
- Collaborate with interdisciplinary teams, including scientists, product managers, and other engineers, to solve complex problems and deliver high- quality software solutions
- Mentor and guide junior engineers, fostering their growth and enhancing the team's technical expertise
- Lead code and design reviews, championing engineering best practices and promoting a culture of quality and collaboration
- Contribute to the development of data infrastructure for machine learning applications, ensuring efficient data processing and integration
- Drive the implementation of engineering hygiene practices, ensuring the reliability and maintainability of our systems
- Advocate for and implement innovative software development methodologies and tools to improve team efficiency and product quality
Our take
Freenome is a biotechnology company offering a biological analysis platform that uses molecular biology and machine learning to detect cancer with a routine blood draw. The platform trains on thousands of cancer-positive blood samples to recognise disease-associated patterns and help detect early-stage cancer, allowing clinicians to optimise treatments.
The company specialises in advanced computational biology, using machine learning to detect patterns among billions of circulating cell-free biomarkers. Freenome continues to focus on the development of its colorectal cancer test, potentially helping the 45 million people not currently up-to-date on colorectal cancer screening guidelines in the United States.
Following its 2022 funding round, the company surpassed the $1 billion funding mark. Freenome is set to accelerate the development of its platform, testing for additional cancers and furthering its blood test detection technology. It's also forming partnerships for R&D purposes, joining forces with health firms such as Geisinger to provide real world data that could help it detect multiple cancers.
Steph
Company Specialist at Welcome to the Jungle
Insights
Company
Funding (last 2 of 7 rounds)
Feb 2024
$254m
LATE VC
Dec 2021
$300m
SERIES D
Total funding: $1.1bn
Company benefits
- Pre-IPO equity
- Flexible PTO (exempt) and generous PTO (non-exempt)
- Comprehensive health coverage, including medical, dental, and vision
- Wellness and mental health resources, including Employee Assistance Programs (EAPs), Paid maternity and paternity leave
- 401(k) plan
- Plus, a variety of other perks, including pre-tax commuter benefits, two paid volunteer days per year, pet insurance, and additional discounts
Company HQ
The East Side, South San Francisco, CA
Articles
Leadership
Riley Ennis
(CPO)Studied at Yale, Johns Hopkins and Dartmouth. Was a Thiel Fellow and co-founded Immudicon and Oncolinx.
Share this job
View 4 more jobs at Freenome